We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
(+36%)
Cap. Flow
-$348M
Cap. Flow
% of AUM
-25.31%
Top 10 Holdings %
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$53.1M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$31.9M |
| 3 |
PF
Pinnacle Foods, Inc.
PF
|
+$27.7M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$5.3M |
| 5 |
Pacira BioSciences
PCRX
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$12.3M |
| 2 |
Insmed
INSM
|
+$7.51M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$6.36M |
| 4 |
DYNC
Vistra Energy Corp.
DYNC
|
+$5.07M |
| 5 |
NXH
Neighborhood Intelligence Inc
NXH
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.94% |
| 2 | Technology | 3.93% |
| 3 | Industrials | 2.49% |
| 4 | Consumer Staples | 2.13% |
| 5 | Healthcare | 0.93% |
Similar funds
FFM
AWA
SC
HCM
NB
WFA
APF
RIM
DLD Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.
Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.
- DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
- DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
- DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
- DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
- DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
- DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
- DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.
Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.